UCB (PK) Stock Quote UCBJY - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

89.42

Bid

87.45

Ask

90.02

Volume

2,609

88.73 Day's Range 89.44

34.85 52 Week Range 91.89

Market Cap

33.907B

Previous Close

88.97

Open

88.74

Last Trade

510

89.42

(formt)

Last Trade Time

Financial Volume

$ 232,225

VWAP

89.0092

Average Volume (3m)

13,674

Shares Outstanding

379,189,796

Dividend Yield

1.03%

PE Ratio

176.93

Earnings Per Share (EPS)

0.9

Revenue

4.87B

Net Profit

343M

UCB, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. UCB, Brussels, Belgium is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

Sector

Pharmaceutical Preparations

Industry

Chemicals & Allied Products

Website

www.ucb.com

Headquarters

Brussels, Brussels-capital Region, Bel

Founded

1928

UCB (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker UCBJY. The last closing price for UCB (PK) was $88.97. Over the last year, UCB (PK) shares have traded in a share price range of $ 34.85 to $ 91.89.

UCB (PK) currently has 379,189,796 shares outstanding. The market capitalization of UCB (PK) is $33.74 billion. UCB (PK) has a price to earnings ratio (PE ratio) of 176.93.

UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services

UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services Judges highlight value-added partnership and finance transformation as leading examples of innovation in...

New Data Identify Important Factors that May Reduce Hospitalizations among People with Epilepsy in the U.S.

New Data Identify Important Factors that May Reduce Hospitalizations among People with Epilepsy in the U.S. Results of retrospective analysis show use of newer anti-epilepsy drugs, access to...

UCB Announces Crohn's Disease Data to be Presented at Digestive Disease Week 2015

UCB Announces Crohn's Disease Data to be Presented at Digestive Disease Week 2015 PR Newswire ATLANTA, May 16, 2015 ATLANTA, May 16, 2015 /PRNewswire/ -- UCB, a global biopharmaceutical company...

UCB announces US and EU regulatory filings for the investigational antiepileptic drug brivaracetam

UCB announces US and EU regulatory filings for the investigational antiepileptic drug brivaracetam - Major milestone for brivaracetam is latest step towards UCB goal of extending treatment...

UCB and Emory Present New Assessment of Epilepsy Prevalence and Incidence in the U.S. at 2014 American Epilepsy Society Annua...

UCB and Emory Present New Assessment of Epilepsy Prevalence and Incidence in the U.S. at 2014 American Epilepsy Society Annual Meeting PR Newswire ATLANTA, Dec. 8, 2014 ATLANTA, Dec. 8, 2014...

UCB announces first presentation of primary data from latest Phase 3 study evaluating brivaracetam as adjunctive treatment of...

UCB announces first presentation of primary data from latest Phase 3 study evaluating brivaracetam as adjunctive treatment of partial-onset seizures in epilepsy -- Primary efficacy and safety...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.09	0.100750027986	89.33	91.89	87.916	7226	89.66666185	DR
4	-0.18	-0.200892857143	89.6	91.89	87.916	4856	89.83564794	DR
12	15.58	21.0996749729	73.84	91.89	73.515	13674	82.15309429	DR
26	31.0125	53.096776955	58.4075	91.89	58.282	19287	72.26453645	DR
52	45.735	104.692686277	43.685	91.89	34.85	17064	59.4925591	DR
156	34.9	64.0132061629	54.52	91.89	32.82	20927	48.06812106	DR
260	54.32	154.757834758	35.1	91.89	32.45	19672	50.08402654	DR

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
JUVAFJuva Life Inc (CE)	$ 0.002 (199,900.00%)	15.5k
BLSTFBlackstone Minerals Ltd (PK)	$ 0.0271 (27,000.00%)	30k
TLSSTransportation and Logistics Systems Inc (CE)	$ 0.0001 (9,900.00%)	3.1M
GOSYGeckosystems International Corp (CE)	$ 0.0001 (9,900.00%)	1.15M
MMEXMMEX Resources Corporation (PK)	$ 0.0001 (9,900.00%)	745.41k
TEVNFTevano Systems Holdings Inc (CE)	$ 0.000001 (-99.99%)	10k
SNSTSunset Capital Assets Omc (CE)	$ 0.000001 (-99.99%)	85.03k
PNDDFPender Growth Fund Inc (PK)	$ 0.0012 (-99.98%)	100
HLLPFHello Pal International Inc (CE)	$ 0.000001 (-99.90%)	5k
ELOXEloxx Pharmaceuticals Inc (CE)	$ 0.000001 (-99.83%)	297
IMTLImage Protect Inc (PK)	$ 0.0002 (100.00%)	591.38M
TMGIMarquie Group Inc (PK)	$ 0.0001 (0.00%)	244.01M
SINCSincerity Applied Materials Holdings Corporation (PK)	$ 0.001 (42.86%)	214.48M
SIRCSolar Integrated Roofing Corporation (PK)	$ 0.0002 (0.00%)	167.08M
HMBLHUMBL Inc (PK)	$ 0.0001 (-33.33%)	118.85M